Clinical Trials Directory

Trials / Completed

CompletedNCT04585399

Increasing MAT Engagement With Financial Incentives

Increasing MAT Engagement With Contingency Management Among Individuals With Opioid Use Disorder in an ED Bridge Program

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
92 (actual)
Sponsor
Rowan University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The increased prevalence of opioid use disorder (OUD) and associated overdoses and adverse events has led to a substantial increase in the number of patients being seen at emergency departments (ED). Thus, the ED may be an ideal location for identifying patients in need of OUD treatment and can serve as the first touch point in the OUD continuum of care to promote medication assisted treatment initiation. Contingency management (CM) is an effective method for promoting treatment initiation and adherence that has not been thoroughly evaluated for this purpose. The primary aim of the current study is to develop and assess the effectiveness, acceptability, and feasibility of a protocol for delivering CM to increase combined buprenorphine + nalaxone (referred to as BUP hereafter) initiation and continuous adherence for OUD in an existing ED "bridge" program (e.g., Bridge plus CM; B+CM) relative to standard care. Secondary objectives include identifying behavioral and neuropsychological correlates to treatment outcomes, including delay discounting, reinforcer demand, and neurological soft signs.

Conditions

Interventions

TypeNameDescription
BEHAVIORALContingency managementFinancial incentives for attending bup appointments and demonstrating opioid abstinence. Rides will also be provided for up to two clinic visits per week.

Timeline

Start date
2020-01-27
Primary completion
2024-11-01
Completion
2024-11-01
First posted
2020-10-14
Last updated
2025-04-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04585399. Inclusion in this directory is not an endorsement.